Clinical Value Considerations for Gene Therapy in Spinal Muscular Atrophy

Event Type:
Webinars
Date:
Thursday, Jun. 2, 2022, 2-3pm ET

Science & Innovation Webinar Banner

Join us as we explore recent data updates for gene therapy in spinal muscular atrophy (SMA) and gain a deeper understanding of its clinical value.  

In this webinar, experts will share and discuss current data pertaining to motor milestone achievement in presymptomatic patients with 3 copies of survival motor neuron 2 (SMN2). The importance of biodistribution and bulbar function will also be discussed. 

Speakers: 

  • Brian Howell, PharmD 
    Novartis Gene Therapies Regional Medical Director 
  • Nicole LaMarca, DNP 
    Novartis Gene Therapies Global Medical Director, Data Exploration and Generation Lead    

This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. 

Sponsored by: 

Novartis logo

 

For individuals from the media/press who are interested in attending, please email media@amcp.org.  
 

Register Today

Member:
Free
Non-Member:
Free
Register Link